PT1768649E - Composição farmacêutica de derivados de piperazina - Google Patents

Composição farmacêutica de derivados de piperazina Download PDF

Info

Publication number: PT1768649E
Authority: PT; Portugal
Prior art keywords: pharmaceutical composition; piperazine derivatives; piperazine; derivatives; pharmaceutical
Prior art date: 2004-07-14

Application number

PT05758582T

Other languages

English (en)

Portuguese (pt)

Inventor

Domenico Fanara

Jean Scouvart

Claire Poulain

Michel Deelers

Original Assignee

Ucb Farchim Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-07-14

Filing date

2005-07-07

Publication date

2009-11-13

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34925743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1768649(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-07-07 Application filed by Ucb Farchim Sa filed Critical Ucb Farchim Sa

2009-11-13 Publication of PT1768649E publication Critical patent/PT1768649E/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Ophthalmology & Optometry (AREA)
Otolaryngology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Immunology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)

PT05758582T 2004-07-14 2005-07-07 Composição farmacêutica de derivados de piperazina PT1768649E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP04016519		2004-07-14

Publications (1)

Publication Number	Publication Date
PT1768649E true PT1768649E (pt)	2009-11-13

Family

ID=34925743

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT05758582T PT1768649E (pt)	2004-07-14	2005-07-07	Composição farmacêutica de derivados de piperazina

Country Status (25)

Country	Link
US (1)	US8633194B2 (es)
EP (1)	EP1768649B1 (es)
JP (1)	JP4902875B2 (es)
KR (1)	KR101185612B1 (es)
CN (1)	CN100508981C (es)
AR (1)	AR049846A1 (es)
AT (1)	ATE443512T1 (es)
AU (1)	AU2005261953B2 (es)
BR (1)	BRPI0513257C1 (es)
CA (1)	CA2573662A1 (es)
CY (1)	CY1109670T1 (es)
DE (1)	DE602005016802D1 (es)
EA (1)	EA012463B1 (es)
ES (1)	ES2332462T3 (es)
IL (1)	IL180010A0 (es)
MX (1)	MX2007000230A (es)
MY (1)	MY149403A (es)
NO (1)	NO337768B1 (es)
NZ (1)	NZ552182A (es)
PE (1)	PE20060484A1 (es)
PL (1)	PL1768649T3 (es)
PT (1)	PT1768649E (es)
TW (1)	TWI304339B (es)
WO (1)	WO2006005507A2 (es)
ZA (1)	ZA200700939B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT3943069T (pt)	2009-03-17	2025-02-21	Nicox Ophthalmics Inc	Formulações oftálmicas de cetirizina e métodos de utilização
US8569273B2 (en)	2009-03-17	2013-10-29	Aciex Therapeutics, Inc.	Ophthalmic formulations of cetirizine and methods of use
TWI503122B (zh) *	2012-02-15	2015-10-11	Taiho Pharmaceutical Co Ltd	Oral administration of pharmaceutical compositions
KR102155836B1 (ko)	2013-02-22	2020-09-14	삼성전자주식회사	터치 스크린 상에서 객체 디스플레이를 제어하는 휴대 단말 및 방법
US11241426B2 (en) *	2017-02-13	2022-02-08	Nitto Medic Co., Ltd.	Aqueous composition for ophthalmic or nasal administration
CN113712907A (zh) *	2020-05-25	2021-11-30	南京帝昌医药科技有限公司	一种盐酸左西替利嗪滴眼液组合物及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4255358A (en) *	1978-03-13	1981-03-10	The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland	Process for the production of hexanitrostilbene
FI75816C (fi)	1981-02-06	1988-08-08	Ucb Sa	Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
NZ215069A (en)	1985-03-01	1988-06-30	Reckitt & Colmann Prod Ltd	Pharmaceutical composition with histamine h 2 -receptor antagonist
US4728509A (en)	1985-08-19	1988-03-01	Takeda Chemical Industries, Ltd.	Aqueous liquid preparation
JP3278192B2 (ja)	1992-04-03	2002-04-30	ロート製薬株式会社	徐放性液剤
TW401300B (en)	1992-12-25	2000-08-11	Senju Pharma Co	Antiallergic composition for ophthalmic or nasal use
US5504113A (en)	1994-03-02	1996-04-02	Allergan, Inc.	Enhancement of benzalkonium chloride preservative activity in formulations containing an incompatible drug
AU3609795A (en)	1994-10-10	1996-05-02	Novartis Ag	Ophthalmic and aural compositions containing diclofenac potassium
TW536403B (en)	1997-03-24	2003-06-11	Glaxo Group Ltd	An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
US6432961B1 (en)	1998-08-18	2002-08-13	Ucb S.A.	Method for preventing the onset of asthma
AUPQ419099A0 (en)	1999-11-23	1999-12-16	Ko, Thomas Sai Ying	Novel compositions and methods
DE10007203A1 (de)	2000-02-17	2001-08-23	Asta Medica Ag	Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
US6258814B1 (en)	2000-10-13	2001-07-10	Schering Corporation	Method of using cetirizine and pharmaceutical compositions containing the same for inducing sleep
UA80393C2 (uk) *	2000-12-07	2007-09-25	Алтана Фарма Аг	Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
WO2002047689A2 (en)	2000-12-15	2002-06-20	Ucb, S.A.	Use of cetirizine or efletirizine for preventing urticaria
US6869618B2 (en)	2001-04-10	2005-03-22	Kiel Laboratories, Inc.	Process for preparing tannate liquid and semi-solid dosage forms
KR101255356B1 (ko)	2002-06-12	2013-04-17	케모센트릭스, 인크.	염증 및 면역 질병의 치료를 위한 ｃｃｒ１ 길항물질로서사용하기 위한 1-아릴-4-치환된 피페라진 유도체
AU2003251152A1 (en)	2002-07-03	2004-01-23	Shannon Biotechnology Ltd	Pharmaceutical formulations for preparing drink products
PL377470A1 (pl)	2002-12-03	2006-02-06	Ucb Farchim S.A.	Zastosowanie lewocetyryzyny do leczenia przetrwałego alergicznego nieżytu nosa
US20050255154A1 (en)	2004-05-11	2005-11-17	Lena Pereswetoff-Morath	Method and composition for treating rhinitis
US20090137645A1 (en)	2007-10-31	2009-05-28	Midlothian Laboratories, Llc	Shelf-Stable Famotidine Granulates for Oral Suspensions

2005
- 2005-07-04 PE PE2005000777A patent/PE20060484A1/es not_active Application Discontinuation
- 2005-07-06 TW TW094122831A patent/TWI304339B/zh not_active IP Right Cessation
- 2005-07-06 US US10/599,451 patent/US8633194B2/en active Active
- 2005-07-07 ES ES05758582T patent/ES2332462T3/es not_active Expired - Lifetime
- 2005-07-07 AT AT05758582T patent/ATE443512T1/de active
- 2005-07-07 CA CA002573662A patent/CA2573662A1/en not_active Abandoned
- 2005-07-07 ZA ZA200700939A patent/ZA200700939B/xx unknown
- 2005-07-07 KR KR1020077003545A patent/KR101185612B1/ko not_active Expired - Lifetime
- 2005-07-07 WO PCT/EP2005/007340 patent/WO2006005507A2/en not_active Ceased
- 2005-07-07 CN CNB2005800234732A patent/CN100508981C/zh not_active Ceased
- 2005-07-07 EA EA200700067A patent/EA012463B1/ru not_active IP Right Cessation
- 2005-07-07 BR BRPI0513257A patent/BRPI0513257C1/pt active IP Right Grant
- 2005-07-07 MY MYPI20053111A patent/MY149403A/en unknown
- 2005-07-07 JP JP2007520716A patent/JP4902875B2/ja not_active Expired - Lifetime
- 2005-07-07 PT PT05758582T patent/PT1768649E/pt unknown
- 2005-07-07 PL PL05758582T patent/PL1768649T3/pl unknown
- 2005-07-07 EP EP05758582A patent/EP1768649B1/en not_active Revoked
- 2005-07-07 AU AU2005261953A patent/AU2005261953B2/en not_active Expired
- 2005-07-07 NZ NZ552182A patent/NZ552182A/en not_active IP Right Cessation
- 2005-07-07 DE DE602005016802T patent/DE602005016802D1/de not_active Expired - Lifetime
- 2005-07-07 MX MX2007000230A patent/MX2007000230A/es active IP Right Grant
- 2005-07-13 AR ARP050102897A patent/AR049846A1/es not_active Application Discontinuation
2006
- 2006-12-12 IL IL180010A patent/IL180010A0/en unknown
2007
- 2007-02-13 NO NO20070832A patent/NO337768B1/no unknown
2009
- 2009-11-25 CY CY20091101233T patent/CY1109670T1/el unknown

Also Published As

Publication number	Publication date
IL180010A0 (en)	2007-05-15
MY149403A (en)	2013-08-30
EA012463B1 (ru)	2009-10-30
ZA200700939B (en)	2008-08-27
AU2005261953A1 (en)	2006-01-19
HK1103958A1 (zh)	2008-01-04
US8633194B2 (en)	2014-01-21
WO2006005507A3 (en)	2006-04-27
EP1768649B1 (en)	2009-09-23
TWI304339B (en)	2008-12-21
NO337768B1 (no)	2016-06-20
MX2007000230A (es)	2007-03-30
PL1768649T3 (pl)	2010-02-26
CN100508981C (zh)	2009-07-08
AR049846A1 (es)	2006-09-06
PE20060484A1 (es)	2006-07-06
JP4902875B2 (ja)	2012-03-21
KR20070043841A (ko)	2007-04-25
EP1768649A2 (en)	2007-04-04
CA2573662A1 (en)	2006-01-19
US20070275974A1 (en)	2007-11-29
JP2008505949A (ja)	2008-02-28
BRPI0513257B1 (pt)	2018-05-29
AU2005261953B2 (en)	2010-06-03
ATE443512T1 (de)	2009-10-15
CN1984641A (zh)	2007-06-20
CY1109670T1 (el)	2014-08-13
WO2006005507A2 (en)	2006-01-19
TW200605892A (en)	2006-02-16
ES2332462T3 (es)	2010-02-05
NO20070832L (no)	2007-02-13
WO2006005507A8 (en)	2006-12-07
DE602005016802D1 (de)	2009-11-05
BRPI0513257C1 (pt)	2021-05-25
KR101185612B1 (ko)	2012-09-24
BRPI0513257A (pt)	2008-04-29
EA200700067A1 (ru)	2007-08-31
NZ552182A (en)	2010-07-30

Publication	Publication Date	Title
IL192184A0 (en)	2009-02-11	Heterocyclic derivatives and pharmaceutical compositions containing the same
SI1802579T1 (sl)	2014-03-31	Derivati 3-arilaminopiridina
IL190292A (en)	2017-01-31	History of pyridopyrimidinone and their pharmaceutical preparations
IL187603A0 (en)	2008-03-20	Piperazine derivatives and pharmaceutical compositions containing the same
IL194738A0 (en)	2009-08-03	Piperazine derivatives and pharmaceutical compositions containing the same
ZA200504239B (en)	2007-02-28	Pharmaceutical suspension composition
IL191907A0 (en)	2008-12-29	Azepinoindole derivatives as pharmaceutical agents
IL177480A0 (en)	2006-12-10	Pharmaceutical composition
IL208497A0 (en)	2010-12-30	Pharmaceutical compositions containing erythropoietin and derivatives thereof
IL183986A0 (en)	2007-10-31	Pharmaceutical compounds and compositions
IL187534A0 (en)	2008-03-20	Thiazole derivatives, use thereof and pharmaceutical compositions containing them
IL179627A0 (en)	2007-05-15	Particulate-stabilized injectable pharmaceutical compositions of posaconasole
PL1951663T3 (pl)	2017-01-31	Pochodne (R)-aryloalkiloaminowe i zawierające je kompozycje farmaceutyczne
EP1776112A4 (en)	2009-11-25	HETEROCYCLIC COMPOUNDS AS PHARMACEUTICAL AGENTS
IL186252A0 (en)	2008-08-07	Pharmaceutical compositions containing melatonin derivatives
HU0401177D0 (en)	2004-08-30	Pharmaceutical composition
GB2411355B (en)	2006-02-22	Pharmaceutical composition
ZA200700939B (en)	2008-08-27	Pharmaceutical composition of piperazine derivatives
GB0425255D0 (en)	2004-12-15	Pharmaceutical composition
ZA200701932B (en)	2008-08-27	Pharmaceutical composition
IL177301A0 (en)	2006-12-10	Heterocyclyl-substituted hydroxy-6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same
IL191457A0 (en)	2009-08-03	Pharmaceutical compositions containing steroid derivatives
IL177735A0 (en)	2006-12-31	Combined pharmaceutical composition for the inhibition of the decline of cognitive functions
ZA200701931B (en)	2008-10-29	Pharmaceutical composition
IL178201A0 (en)	2006-12-31	Pharmaceutical composition comprising a salt of mirtazapine